Published in Arch Phys Med Rehabil on January 01, 2009
The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb. J Child Orthop (2010) 1.18
Comparison of surface and ultrasound localization to identify forearm flexor muscles for botulinum toxin injections. PM R (2010) 0.88
Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology. Pharmacol Rev (2017) 0.87
OnabotulinumtoxinA muscle injection patterns in adult spasticity: a systematic literature review. BMC Neurol (2013) 0.86
Surface mapping of motor points in biceps brachii muscle. Ann Rehabil Med (2012) 0.81
Spinal plasticity in stroke patients after botulinum neurotoxin A injection in ankle plantar flexors. Physiol Rep (2013) 0.78
The gap between clinical gaze and systematic assessment of movement disorders after stroke. J Neuroeng Rehabil (2012) 0.78
Systematic test of neurotoxin dose and volume on muscle function in a rat model. Muscle Nerve (2014) 0.78
Explanation of timing of botulinum neurotoxin effects, onset and duration, and clinical ways of influencing them. Toxicon (2015) 0.75
Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity. Drug Des Devel Ther (2016) 0.75
Determination of injection site in flexor digitorum longus for effective and safe botulinum toxin injection. Ann Rehabil Med (2015) 0.75
Selection of acupoints for managing upper-extremity spasticity in chronic stroke patients. Clin Interv Aging (2014) 0.75
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol (2010) 5.03
Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Ann Thorac Surg (2006) 2.33
Age and cigarette smoking are independently associated with the cutaneous vascular response to local warming. Microcirculation (2009) 2.05
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84
Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. J Infect Dis (2007) 1.79
Robust crop resistance to broadleaf and grass herbicides provided by aryloxyalkanoate dioxygenase transgenes. Proc Natl Acad Sci U S A (2010) 1.69
Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol (2011) 1.57
Peripheral neuropathy in HIV: prevalence and risk factors. AIDS (2011) 1.53
Low atazanavir concentrations in cerebrospinal fluid. AIDS (2009) 1.45
Hypnosis for treatment of HIV neuropathic pain: a preliminary report. Pain Med (2013) 1.44
Regional patterns of brain metabolites in AIDS dementia complex. Neuroimage (2004) 1.40
AIDS and AIDS-treatment neuropathies. Curr Pain Headache Rep (2002) 1.39
Effect of hypothermia on cerebral blood flow and metabolism in the pig. Ann Thorac Surg (2002) 1.29
Differential input by Ste5 scaffold and Msg5 phosphatase route a MAPK cascade to multiple outcomes. EMBO J (2004) 1.27
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon (2013) 1.27
JC virus granule cell neuronopathy is associated with VP1 C terminus mutants. J Gen Virol (2011) 1.25
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV. J Antimicrob Chemother (2010) 1.19
Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr (2011) 1.16
Autonomic dysfunction is common in HIV and associated with distal symmetric polyneuropathy. J Neurovirol (2013) 1.10
Sex-specific programming of cardiovascular physiology in children. Eur Heart J (2008) 1.10
Diagnosis and management of HIV-associated neuropathy. Neurol Clin (2008) 1.09
Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann Neurol (2008) 1.08
Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder. Clin Infect Dis (2013) 1.05
Unilateral stimulation of the subthalamic nucleus in Parkinson disease: a double-blind 12-month evaluation study. J Neurosurg (2004) 1.05
Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN. Epilepsia (2012) 1.04
Size at birth and autonomic function during psychological stress. Hypertension (2007) 1.01
A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury. Arch Phys Med Rehabil (2009) 0.99
Neuromuscular diseases associated with HIV-1 infection. Muscle Nerve (2009) 0.99
Spinal cord blood flow and ischemic injury after experimental sacrifice of thoracic and abdominal segmental arteries. Eur J Cardiothorac Surg (2008) 0.99
Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome. Toxicon (2012) 0.98
A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy. J Acquir Immune Defic Syndr (2012) 0.97
A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain. PLoS One (2007) 0.97
Evolving compartment syndrome detected by loss of somatosensory- and motor-evoked potential signals during cervical spine surgery. Orthopedics (2012) 0.95
Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir. J Acquir Immune Defic Syndr (2012) 0.95
The roles of ethnicity and antiretrovirals in HIV-associated polyneuropathy: a pilot study. J Acquir Immune Defic Syndr (2009) 0.95
Role of metabolic syndrome components in HIV-associated sensory neuropathy. AIDS (2009) 0.95
Objective detection of evoked potentials using a bootstrap technique. Med Eng Phys (2006) 0.94
HIV-related neurocognitive impairment in the HAART era. Curr HIV/AIDS Rep (2009) 0.93
Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort. Arch Neurol (2008) 0.93
Localized feedback phosphorylation of Ste5p scaffold by associated MAPK cascade. J Biol Chem (2004) 0.92
Spinal cord perfusion after extensive segmental artery sacrifice: can paraplegia be prevented? Eur J Cardiothorac Surg (2007) 0.92
Detection of impaired cerebral autoregulation improves by increasing arterial blood pressure variability. J Cereb Blood Flow Metab (2012) 0.91
Managing HIV peripheral neuropathy. Curr HIV/AIDS Rep (2007) 0.91
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol (2013) 0.91
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration. J Antimicrob Chemother (2012) 0.90
Fatigue after traumatic brain injury and its impact on participation and quality of life. J Head Trauma Rehabil (2008) 0.90
Peripheral neuropathies associated with HIV and hepatitis C co-infection: a review. AIDS (2005) 0.90
Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain. J Pain Res (2011) 0.89
Patient characteristics and anesthetic technique are additive but not synergistic predictors of successful motor evoked potential monitoring. Anesth Analg (2010) 0.89
Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity. Psychosomatics (2012) 0.89
Neuromuscular complications of human immunodeficiency virus infection. Phys Med Rehabil Clin N Am (2008) 0.88
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. J Neurovirol (2006) 0.86
NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials. AIDS Res Ther (2013) 0.86
Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol (2012) 0.85
Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER. J Neurovirol (2012) 0.85
Botulinum toxin for neuropathic pain and spasticity: an overview. Pain Manag (2014) 0.85
Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study. AIDS Res Ther (2011) 0.85
Anatomical localization of motor endplate bands in the human biceps brachii. J Clin Neuromuscul Dis (2007) 0.85
Heart-rate and blood-pressure variability during psychophysiological tasks involving speech: influence of respiration. Psychophysiology (2007) 0.84
Therapeutic amprenavir concentrations in cerebrospinal fluid. Antimicrob Agents Chemother (2012) 0.84
Peripheral neuropathy in HIV infection. Handb Clin Neurol (2007) 0.84
Postural sway changes during pregnancy: a descriptive study using stabilometry. Eur J Obstet Gynecol Reprod Biol (2009) 0.84
Simplification of the research diagnosis of HIV-associated sensory neuropathy. HIV Clin Trials (2009) 0.84
Prophylaxis for venous thromboembolism during rehabilitation for traumatic brain injury: a multicenter observational study. J Trauma (2010) 0.84
Reliability and sensitivity of a wrist rig to measure motor control and spasticity in poststroke hemiplegia. Neurorehabil Neural Repair (2008) 0.83
Contralateral weakness following botulinum toxin for poststroke spasticity. Muscle Nerve (2012) 0.83
Understanding the etiology and management of HIV-associated peripheral neuropathy. Curr HIV/AIDS Rep (2014) 0.81
Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons. J Neuropsychiatry Clin Neurosci (2011) 0.81
Problematic prescription opioid use in an HIV-infected cohort: the importance of universal toxicology testing. J Acquir Immune Defic Syndr (2012) 0.81
Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Virology (2012) 0.81
Cdc24 regulates nuclear shuttling and recruitment of the Ste5 scaffold to a heterotrimeric G protein in Saccharomyces cerevisiae. J Biol Chem (2005) 0.81
HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter. J Neurovirol (2014) 0.81
Pathways in the diagnosis and management of diabetic polyneuropathy. Curr Diab Rep (2015) 0.81
Impact of high intracranial pressure on neurophysiological recovery and behavior in a chronic porcine model of hypothermic circulatory arrest. Eur J Cardiothorac Surg (2002) 0.80
Neuromuscular complications in HIV: effects of aging. J Neurovirol (2011) 0.80
HIV neuropathy. Curr Opin HIV AIDS (2014) 0.80
The relationship between upper limb activity and impairment in post-stroke hemiplegia. Disabil Rehabil (2009) 0.79
Effects of assisted and variable mechanical ventilation on cardiorespiratory interactions in anesthetized pigs. Physiol Meas (2012) 0.79
The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV. Am J Epidemiol (2014) 0.79
Low-frequency heart rate variability is related to the breath-to-breath variability in the respiratory pattern. Psychophysiology (2013) 0.78
A system identification analysis of neural adaptation dynamics and nonlinear responses in the local reflex control of locust hind limbs. J Comput Neurosci (2012) 0.78
Use of a maze to detect cognitive dysfunction in a porcine model of hypothermic circulatory arrest. Ann Thorac Surg (2005) 0.78
Ste11p MEKK signals through HOG, mating, calcineurin and PKC pathways to regulate the FKS2 gene. BMC Mol Biol (2011) 0.78
Random perturbations of arterial blood pressure for the assessment of dynamic cerebral autoregulation. Physiol Meas (2012) 0.78
The dynamics of analogue signalling in local networks controlling limb movement. Eur J Neurosci (2012) 0.77
Tracking instantaneous pressure-to-flow dynamics of cerebral autoregulation induced by CO2 reactivity. Conf Proc IEEE Eng Med Biol Soc (2013) 0.77
Gain and coherence estimates between respiration and heart-rate: differences between inspiration and expiration. Auton Neurosci (2013) 0.77
Understanding neuronal systems in movement control using Wiener/Volterra kernels: a dominant feature analysis. J Neurosci Methods (2011) 0.77
Comparison of human expert and computer-automated systems using magnitude-squared coherence (MSC) and bootstrap distribution statistics for the interpretation of pattern electroretinograms (PERGs) in infants with optic nerve hypoplasia (ONH). Doc Ophthalmol (2015) 0.77
Pilot study of intravenous immunoglobulin in HIV-associated myelopathy. AIDS Patient Care STDS (2009) 0.76
Myopathy in HIV infection. Handb Clin Neurol (2007) 0.76
Spastic cocontraction in hemiparesis: effects of botulinum toxin. Muscle Nerve (2012) 0.76
Challenges in developing novel therapies for peripheral neuropathies: a summary of The Foundation for Peripheral Neuropathy Scientific Symposium 2012. J Peripher Nerv Syst (2013) 0.76
Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia. Curr HIV Res (2016) 0.76
Safety profile of treatment in diabetic peripheral neuropathic pain. Pain Med (2007) 0.76
Revisiting the frequency domain: the multiple and partial coherence of cerebral blood flow velocity in the assessment of dynamic cerebral autoregulation. Physiol Meas (2016) 0.76
Cutaneous vascular response to local warming: a response to letter from Cracowski and Roustit. Microcirculation (2010) 0.75